CCM
BLUE

Camber Capital Management’s bluebird bio BLUE Stock Holding History

Camber Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-77,200
Closed -$30.1M – 35
2021
Q1 		$30.1M Buy
77,200
+15,440
+25% +$7.6M 1.03% 28
2020
Q4 		$34.6M Sell
61,760
-23,160
-27% -$14.7M 1.21% 27
2020
Q3 		$59.3M Sell
84,920
-13,510
-14% -$10.5M 3.13% 12
2020
Q2 		$77.8M Buy
+98,430
New +$74.2M 4.45% 8
2014
Q3 		– Sell
-50,713
Closed -$25.3M – 38
2014
Q2 		$25.3M Sell
50,713
-3,860
-7% -$1.24M 1.66% 21
2014
Q1 		$16.1M Buy
54,573
+38,600
+242% +$11.7M 1.26% 24
2013
Q4 		$4.34M Buy
15,973
+4,393
+38% +$1.23M 0.38% 35
2013
Q3 		$4.04M Hold
11,580
– – 0.42% 33
2013
Q2 		$3.75M Buy
+11,580
New +$3.82M 0.39% 41

Other funds holding BLUE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Camber Capital Management's BLUE Position: Q2 2021 in Review

Camber Capital Management sold out of bluebird bio (BLUE) in Q2 2021, closing a stake of 77,200 shares — an estimated $30.1M sold.

Camber Capital Management first reported a position in BLUE in Q2 2013 and held it in 9 quarters. The position peaked at $77.8M in Q2 2020. 232 funds tracked by Wall St. Rank hold BLUE as of Q2 2021.

  • Camber Capital Management reported no remaining bluebird bio position as of Q2 2021 after selling out during the quarter.
  • Camber Capital Management sold 77,200 bluebird bio shares in Q2 2021, an estimated $30.1M.
  • Camber Capital Management first reported a position in bluebird bio in Q2 2013 and held it in 9 quarters.
  • Camber Capital Management's bluebird bio position peaked at $77.8M in Q2 2020.
  • 232 funds tracked by Wall St. Rank held bluebird bio as of Q2 2021.

Based on Camber Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.